Author: eqs

CF PharmTech (HKEX: 2652.HK) Announces NMPA Acceptance of IND Application for ICF004, a Potential First-in-Class Inhaled Dry Powder Candidate Targeting Unmet Needs in PF-ILD

EQS via SeaPRwire.com / 25/02/2026 / 11:12 UTC+8 Suzhou, China, February 24, 2026 — CF PharmTech, Inc. (HKEX: 2652.HK) (“CF PharmTech” or the “Company”) today announced that the Investigational New Drug (“IND”) application for ICF004, the Company’s internally developed first-in-class

More

Q4 and FY 2025 production results

EQS via SeaPRwire.com / 02/02/2026 / 05:07 MSK Solidcore Resources plc (“Solidcore” or the “Company”) announces production results for the fourth quarter and FY 2025. “Q4 was marked by substantial destockpiling which, together with very favourable gold prices, helped to

More